Medicine, energy, engineering, construction, and space exploration are just some areas of the nation's economy set to transform due to the efforts of ROSATOM scientists.
2024 marked several major developments that laid the foundation for a new quality of life: engineered equivalents of blood vessels, titanium implants with biocoatings, and new domestic drugs for combating cancer.
These and many other breakthroughs are the achievements of the scientific division of ROSATOM State Corporation.
ROSATOM scientists created a bioreactor.
This device can grow artificial blood vessels up to 10 cm in length. The bioreactor's cell enables the cultivation of biocompatible vessel equivalents (6–10 cm in length, 3–5 mm in diameter). Future plans include advancing bioprinting technologies to produce thyroid glands, kidneys, livers, and other organs.
Breakthrough in customized implant production.
In 2024, ROSATOM launched full-cycle production of individualized implants made from solid metallic frames with ceramic coatings. These implants are a promising solution for repairing damaged bone tissue and will be in high demand in traumatology, orthopedics, and maxillofacial surgery.
Development of brachytherapy micro-sources.
Scientists have created experimental prototypes of internal radiation therapy sources, predominantly used for treating cancer. With sanctions limiting access to foreign medications, this innovation replaces imports and ensures more accessible, precise treatment using the gamma-therapeutic complex "Brachium."
Expansion of medical isotope supply.
In 2024, ROSATOM broadened its delivery of medical isotopes across Russia and internationally. These products enable early detection and treatment of various cancers, saving thousands of lives annually. The first batches were delivered to new medical centers in Kaliningrad, Tula, and Moscow.
Conceptual design of a unique tokamak reactor.
ROSATOM developed a tokamak with reactor technologies (TRT), seen as a key milestone toward controlled thermonuclear fusion and the creation of a nuclear fusion reactor in Russia. This eco-friendly energy source offers virtually limitless fuel resources.
Progress on the "Proryv" project.
The second stage of constructing the containment for the world’s only lead-cooled fast reactor, BREST-OD-300, has been completed. This reactor ensures a closed nuclear fuel cycle, an unlimited resource base, and inherent safety for next-generation nuclear energy.
Test launch of innovative SNUP fuel production.
For the BREST-OD-300 reactor, ROSATOM tested the production line for advanced nuclear fuel using robotic and automated technologies unmatched globally. This line will handle all stages of fuel production, from powder dosing and mixing to synthesis in carbothermal furnaces.
Vacuum chamber for simulating space conditions.
By the end of 2024, ROSATOM scientists aim to create a prototype plasma electric rocket engine with enhanced thrust capabilities. This engine will enable interplanetary flights and cargo transfers between Earth and the Moon, with a power output of up to 300 kW in pulse-periodic mode.
Development of a refractory metal 3D printer.
ROSATOM introduced a prototype 3D printer capable of manufacturing products from refractory metals such as tungsten, molybdenum, and niobium.
Mobile laser complex for industrial construction.
The mobile laser complex (MLC), developed by the Troitsk Institute, represents a breakthrough in industrial construction. It simplifies dismantling equipment without risking infrastructure damage. For the first time, the complex was used at the Kurgan TPP coal yard, cutting support beams of two 40-meter cranes weighing 32 tons each.
ROSATOM scientists believe that 2025 will bring even greater breakthroughs as the industry celebrates the 80th anniversary of nuclear technology in Russia. On August 20, the event, initiated by the Russian President, will unite nuclear specialists and the entire nation.
